Financials Autonomix Medical, Inc.
Equities
AMIX
US05330T1060
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.28 USD | +7.55% | -2.36% | -.--% |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2022 | 2023 |
---|---|---|
Net sales | - | - |
EBITDA | - | - |
EBIT 1 | -13.59 | -1.99 |
Operating Margin | - | - |
Earnings before Tax (EBT) 1 | -13.33 | -1.99 |
Net income 1 | -13.33 | -1.99 |
Net margin | - | - |
EPS 2 | -6.197 | -0.1656 |
Free Cash Flow | - | -1.108 |
FCF margin | - | - |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 7/7/23 | 7/7/23 |
Balance Sheet Analysis
Fiscal Period: March | 2022 | 2023 |
---|---|---|
Net Debt 1 | - | - |
Net Cash position 1 | 2.04 | 0.86 |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | -1.11 |
ROE (net income / shareholders' equity) | - | -153% |
ROA (Net income/ Total Assets) | - | -85.3% |
Assets 1 | - | 2.334 |
Book Value Per Share 2 | 0.9500 | 0.0500 |
Cash Flow per Share 2 | 0.9900 | 0.0700 |
Capex | - | - |
Capex / Sales | - | - |
Announcement Date | 7/7/23 | 7/7/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 42.89M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- AMIX Stock
- Financials Autonomix Medical, Inc.